129 related articles for article (PubMed ID: 2163309)
1. Evidence for calcitonin receptor heterogeneity: binding studies with nonhelical analogs.
Nakamuta H; Orlowski RC; Epand RM
Endocrinology; 1990 Jul; 127(1):163-9. PubMed ID: 2163309
[TBL] [Abstract][Full Text] [Related]
2. Divergent structural requirements exist for calcitonin receptor binding specificity and adenylate cyclase activation.
Houssami S; Findlay DM; Brady CL; Martin TJ; Epand RM; Moore EE; Murayama E; Tamura T; Orlowski RC; Sexton PM
Mol Pharmacol; 1995 Apr; 47(4):798-809. PubMed ID: 7723741
[TBL] [Abstract][Full Text] [Related]
3. Determinants for calcitonin analog interaction with the calcitonin receptor N-terminus and transmembrane-loop regions.
Stroop SD; Nakamuta H; Kuestner RE; Moore EE; Epand RM
Endocrinology; 1996 Nov; 137(11):4752-6. PubMed ID: 8895343
[TBL] [Abstract][Full Text] [Related]
4. Biologically active, derivatizable salmon calcitonin analog: design, synthesis, and applications.
D'Santos CS; Nicholson GC; Moseley JM; Evans T; Martin TJ; Kemp BE
Endocrinology; 1988 Sep; 123(3):1483-8. PubMed ID: 2841096
[TBL] [Abstract][Full Text] [Related]
5. [Centrally and peripherally induced anorectic actions of salmon calcitonin (sCT) in rats: separation of its novel derivative [Gly8]-sCT].
Nakamuta H; Koida M; Ogawa Y; Orlowski RC
Nihon Yakurigaku Zasshi; 1987 Apr; 89(4):191-5. PubMed ID: 3038715
[TBL] [Abstract][Full Text] [Related]
6. A noncyclical analog of salmon calcitonin (N alpha-propionyl Di-Ala1,7,des-Leu19 sCT) retains full potency without inducing anorexia in rats.
Yates AJ; Gutierrez GE; Garrett IR; Mencel JJ; Nuss GW; Schreiber AB; Mundy GR
Endocrinology; 1990 Jun; 126(6):2845-9. PubMed ID: 2351097
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and utility of novel benzophenone-containing calcitonin analogs for photoaffinity labeling the calcitonin receptor.
Suva LJ; Flannery MS; Caulfield MP; Findlay DM; Jüppner H; Goldring SR; Rosenblatt M; Chorev M
J Pharmacol Exp Ther; 1997 Nov; 283(2):876-84. PubMed ID: 9353409
[TBL] [Abstract][Full Text] [Related]
8. Calcitonin receptor down-regulation relates to calcitonin resistance in mature mouse osteoclasts.
Wada S; Udagawa N; Nagata N; Martin TJ; Findlay DM
Endocrinology; 1996 Mar; 137(3):1042-8. PubMed ID: 8603572
[TBL] [Abstract][Full Text] [Related]
9. Calcitonin receptor regulation and responsiveness to calcitonin in human osteoclast-like cells prepared in vitro using receptor activator of nuclear factor-kappaB ligand and macrophage colony-stimulating factor.
Samura A; Wada S; Suda S; Iitaka M; Katayama S
Endocrinology; 2000 Oct; 141(10):3774-82. PubMed ID: 11014233
[TBL] [Abstract][Full Text] [Related]
10. Physiological levels of calcitonin regulate the mouse osteoclast calcitonin receptor by a protein kinase Alpha-mediated mechanism.
Wada S; Udagawa N; Nagata N; Martin TJ; Findlay DM
Endocrinology; 1996 Jan; 137(1):312-20. PubMed ID: 8536630
[TBL] [Abstract][Full Text] [Related]
11. Biological activities and receptor interactions of des-Leu16 salmon and des-Phe16 human calcitonin.
Findlay DM; Michelangeli VP; Orlowski RC; Martin TJ
Endocrinology; 1983 Apr; 112(4):1288-91. PubMed ID: 6299689
[TBL] [Abstract][Full Text] [Related]
12. Homologous regulation of the calcitonin receptor in mouse osteoclast-like cells and human breast cancer T47D cells.
Wada S; Martin TJ; Findlay DM
Endocrinology; 1995 Jun; 136(6):2611-21. PubMed ID: 7750484
[TBL] [Abstract][Full Text] [Related]
13. Effects of continuous calcitonin treatment on osteoclasts derived from cocultures of mouse marrow stromal and spleen cells.
Liu BY; Wang JT; Leu JS; Chiang CP; Hsieh CC; Kwan HW
J Formos Med Assoc; 2000 Feb; 99(2):140-50. PubMed ID: 10770029
[TBL] [Abstract][Full Text] [Related]
14. Human placental calcitonin receptors.
Nicholson GC; D'Santos CS; Evans T; Moseley JM; Kemp BE; Michelangeli VP; Martin TJ
Biochem J; 1988 Mar; 250(3):877-82. PubMed ID: 2839149
[TBL] [Abstract][Full Text] [Related]
15. Expression of a novel receptor for the calcitonin peptide family and a salmon calcitonin-like peptide in the alpha-thyrotropin thyrotroph cell line.
Hanna FW; Smith DM; Johnston CF; Akinsanya KO; Jackson ML; Morgan DG; Bhogal R; Buchanan KD; Bloom SR
Endocrinology; 1995 Jun; 136(6):2377-82. PubMed ID: 7750458
[TBL] [Abstract][Full Text] [Related]
16. Identification of key components in the irreversibility of salmon calcitonin binding to calcitonin receptors.
Hilton JM; Dowton M; Houssami S; Sexton PM
J Endocrinol; 2000 Jul; 166(1):213-26. PubMed ID: 10856900
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of rat kidney calcitonin receptors by salmon calcitonin infusion evidenced by autoradiography.
Bouizar Z; Rostène WH; Milhaud G
Proc Natl Acad Sci U S A; 1987 Aug; 84(15):5125-8. PubMed ID: 3037535
[TBL] [Abstract][Full Text] [Related]
18. Relationship between internalization and calcitonin-induced receptor loss in T 47D cells.
Findlay DM; Martin TJ
Endocrinology; 1984 Jul; 115(1):78-83. PubMed ID: 6329663
[TBL] [Abstract][Full Text] [Related]
19. Biologically active calcitonin analogs which have minimal interactions with phospholipids.
Epand RM; Epand RF; Orlowski RC
Biochem Biophys Res Commun; 1988 Apr; 152(1):203-7. PubMed ID: 3358761
[TBL] [Abstract][Full Text] [Related]
20. Analogue separates biological effects of salmon calcitonin on brain and renal cortical membranes.
Twery MJ; Seitz PK; Nickols GA; Cooper CW; Gallagher JP; Orlowski RC
Eur J Pharmacol; 1988 Oct; 155(3):285-92. PubMed ID: 3266153
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]